Clinical Trial Update: An Exploratory Open Label Study of Adjunctive L-lysine Treatment in Patients With Schizophrenia [NA]

View source ↗

Summary

An exploratory open-label trial evaluating adjunctive L-lysine therapy for schizophrenia has completed. Sponsor: Göteborg University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• L-lysine (L-lysine)

Snippet

Sponsor: Göteborg University | Conditions: Schizophrenia | NA | Status: COMPLETED